Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Long-Term Debt Repayments (2020 - 2023)

Historic Long-Term Debt Repayments for Aptevo Therapeutics (APVO) over the last 4 years, with Q1 2023 value amounting to $3.5 million.

  • Aptevo Therapeutics' Long-Term Debt Repayments fell 6779.98% to $3.5 million in Q1 2023 from the same period last year, while for Sep 2023 it was $4.0 million, marking a year-over-year decrease of 6628.71%. This contributed to the annual value of $3.5 million for FY2023, which is 7173.72% down from last year.
  • Aptevo Therapeutics' Long-Term Debt Repayments amounted to $3.5 million in Q1 2023, which was down 6779.98% from $500000.0 recorded in Q4 2022.
  • Over the past 5 years, Aptevo Therapeutics' Long-Term Debt Repayments peaked at $22.1 million during Q1 2020, and registered a low of $500000.0 during Q2 2022.
  • Over the past 4 years, Aptevo Therapeutics' median Long-Term Debt Repayments value was $4.2 million (recorded in 2021), while the average stood at $6.0 million.
  • Data for Aptevo Therapeutics' Long-Term Debt Repayments shows a peak YoY increase of 11534.0% (in 2022) and a maximum YoY decrease of 9099.1% (in 2022) over the last 5 years.
  • Aptevo Therapeutics' Long-Term Debt Repayments (Quarter) stood at $22.1 million in 2020, then plummeted by 74.89% to $5.6 million in 2021, then plummeted by 90.99% to $500000.0 in 2022, then skyrocketed by 593.4% to $3.5 million in 2023.
  • Its last three reported values are $3.5 million in Q1 2023, $500000.0 for Q4 2022, and $500000.0 during Q3 2022.